Tekla Capital Management’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $1.42M | Hold |
148,874
| – | – | 0.06% | 121 |
|
|
2023
Q1 | $1.64M | Hold |
148,874
| – | – | 0.06% | 127 |
|
|
2022
Q4 | $2.2M | Hold |
148,874
| – | – | 0.08% | 111 |
|
|
2022
Q3 | $2.85M | Hold |
148,874
| – | – | 0.12% | 100 |
|
|
2022
Q2 | $3.17M | Buy |
148,874
+17,241
| +13% | +$367K | 0.12% | 101 |
|
|
2022
Q1 | $2.54M | Hold |
131,633
| – | – | 0.09% | 119 |
|
|
2021
Q4 | $2.73M | Hold |
131,633
| – | – | 0.09% | 120 |
|
|
2021
Q3 | $3.15M | Hold |
131,633
| – | – | 0.1% | 125 |
|
|
2021
Q2 | $3.59M | Hold |
131,633
| – | – | 0.12% | 133 |
|
|
2021
Q1 | $3.81M | Buy |
+131,633
| New | +$3.81M | 0.13% | 136 |
|